Moderna To Pay Up To $2.25B To Settle Patent Suit Over COVID-19 Vaccine Technology
If Moderna's full financial payout to the companies is reached, it would rank among the largest disclosed patent settlements in biopharmaceutical industry history.
If Moderna's full financial payout to the companies is reached, it would rank among the largest disclosed patent settlements in biopharmaceutical industry history.
The case highlights ongoing questions about governance and standards for national health data sharing, with Health Gorilla arguing the dispute should be handled through interoperability networks’ internal processes rather than in federal court.
With the addition of Uncover’s technology, the litigation software is delivering rapid innovation.
The case highlights federal and state scrutiny of hospital consolidation and restrictive contracting practices — with potential implications for payers, patients and healthcare markets across the country.
The FDA’s refuse-to-file letter cited no safety or efficacy concerns. The company said the agency’s justification for refusing a review is inconsistent with guidance given prior to the start of Phase 3 testing.
The Consolidated Appropriations Act of 2026 and the Department of Labor’s proposed rule implement major PBM reforms for employers, but don’t include everything they want, including a ban on spread pricing.
HHS is scrapping its proposed 340B rebate pilot after hospitals sued to stop it. Providers say the plan would have created cash flow problems and administrative burdens that threatened safety-net care.
Takeaways from a Legalweek panel on evolving malpractice risks.
The No Surprises Act protected patients from surprise bills, but its Independent Dispute Resolution process has become controversial as insurers accuse some providers of exploiting it at scale.
Epic’s lawsuit against Health Gorilla is less about one alleged data misuse scheme and more about a deeper fault line in healthcare interoperability.
During two House hearings, health insurance CEOs were questioned on rising healthcare costs, vertical integration, and prior authorization.
The proposal maintains key programs like CMS coverage for telehealth and hospital-at-home care, but stops short of renewing enhanced ACA premium tax credits.
Legal and operational leaders are gathering May 6–7 in Fort Lauderdale to confront the questions the industry hasn't answered—with a keynote from Amanda Knox setting the tone.
Healthcare executives say the proposal lacks sufficient detail to assess whether it would meaningfully reduce costs.
They allege the company exploited interoperability networks to improperly access and monetize nearly 300,000 patient medical records without consent.
HHS proposed changes that would roll back many Biden-era policies, eliminate most health tech certification criteria, and scrap planned transparency requirements for healthcare AI tools.
A coalition of major pharmacy organizations urged Congressional leaders to enact long-stalled PBM reforms to curb anti-competitive practices, lower drug costs, and stop accelerating pharmacy closures that are limiting patient access to care.
The Senate’s rejection of two ACA-focused bills sparked warnings that the move will raise premiums and reduce affordable coverage.